HÜSEYİN ABALI

Yayın Ağı

Makaleler 13

1. A Post-International Gastrointestinal Cancers Conference (IGICC) Position Statements '

YALÇIN Ş., Lacin S., Kaseb A. O., PEYNİRCİOĞLU B., Cantasdemir M., ÇİL B. E., et al.

JOURNAL OF HEPATOCELLULAR CARCINOMA , cilt.11, ss.953-974, 2024 (SCI-Expanded, Scopus)

2. Tendency of cancer patients and their relatives to use Internet for health-related searches: Turkish Oncology Group (TOG) Study

Nayir E., TANRIVERDİ Ö., Karakas Y., KILIÇKAP S., Turhal N. S., Avci N., et al.

JOURNAL OF BUON , cilt.21, sa.3, ss.714-719, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience

Ozdemir N., Dogan M., ŞENDUR M. A. N., Yazici O., ABALI H., Yazilitas D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.20, ss.8715-8718, 2014 (SCI-Expanded, Scopus)

4. Thymic epithelial neoplasia - A study of 58 cases

ELKIRAN E. T., Abali H., Aksoy S., Altundag K., Erman M., Kars A., et al.

MEDICAL ONCOLOGY , cilt.24, sa.2, ss.197-201, 2007 (SCI-Expanded, Scopus)

5. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: A comparison of efficacy, side-effect profile, and cost

Abali H., Celik I.

CANCER INVESTIGATION , cilt.25, sa.3, ss.135-139, 2007 (SCI-Expanded, Scopus)

6. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient

Aksoy S., Abali H., Kilickap S., Erman M., Kars A.

CLINICAL AND LABORATORY HAEMATOLOGY , cilt.28, sa.3, ss.211-214, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Metastatic granular cell tumor: A case report and review of the literature

Aksoy S., Abali H., Kilickap S., HARPUTLUOĞLU H., Erman M.

ACTA ONCOLOGICA , cilt.45, sa.1, ss.91-94, 2006 (SCI-Expanded, Scopus)

8. Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma

Aksoy S., Abali H., Kilickap S., GÜLER N.

JOURNAL OF NEURO-ONCOLOGY , cilt.71, sa.3, ss.333-334, 2005 (SCI-Expanded, Scopus)

9. Fludarabine phosphate may be useful in the treatment of graft-versus-host disease

Aksoy S., Abali H., Kilickap S., DİNÇER M., Erman M.

MEDICAL HYPOTHESES , cilt.64, sa.6, ss.1150-1152, 2005 (SCI-Expanded, Scopus)

10. CA 19-9 measurement as a screening: Higher cost, lower survival

Kilickap S., Abali H., Aksoy S., Celik I.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.19, sa.12, ss.1428, 2004 (SCI-Expanded, Scopus)

11. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?

Erman M., Abali H., ORAN B., Haznedaroglu I., Canpinar H., KİRAZLI Ş., et al.

ANNALS OF ONCOLOGY , cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Coincidental detection of T-cell rich B cell lymphoma in the para-aortic lymph nodes of a woman undergoing lymph node dissection for cervical cancer: A case report

Abali H., Eren O. Ö., Erman M., Uner A., Kose F., GÜLER N.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.13, sa.5, ss.687-689, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemia

AKSOY D., TURKER A., ALTUNDAG M. K., ABALI H., DURUSU M., ERMAN M., et al.

CHEMOTHERAPY , cilt.49, sa.5, ss.264-266, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study).

Abali H., Yalcin S., Onal C., Dane F., Oksuzoglu B., Ozdemir N., et al.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Utilization of advanced molecular analyses in lung cancer: A country perspective-Young Research Group.

Petekkaya H. I., Abali H.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri) Sürdürülebilir Kalkınma

3. A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastro-esophageal junction cancer (TOXAG study).

Abali H., Yalcin S., Onal H. C., Dane F., Oksuzoglu B., Ozdemir N., et al.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 21 - 23 Ocak 2016, cilt.34, (Özet Bildiri)

4. Turkish National Gastric Cancer Registry.

Buyukberber S., Dumanli E., Uncu D., Ozkan M., Uslu R., Dogu G. G., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey

Celik I., Mandel N. M., Gokmen E., Unal O. U., Sevinc A., Coskun H. S., et al.

6. Turkish National Colon Cancer Registry.

Benekli M., Dumanli E., Kilickap S., Uncu D., Aliustaoglu M., Cicin I., et al.

7. Retrospective review of modified dose docetaxel, cisplatin, and 5-flourouracil (DCF) for the treatment of first-line metastatic gastric carcinomas.

Ozdemir N., Aksoy S., Eren T., Abali H., Oksuzoglu O. B., Zengin N.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

136

H-İndeks (WoS)

Atıf (Scopus)

140

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler